laboratori corp america hold
laboratori corp america hold || north
laboratori corp america
guidanc reduct volum soft importantli bulk volum
headwind stem time direct consum busi weak
core oper issu weigh result rank impact earn
slowdown demand higher margin fell amazon
cyber-monday top sell product list lower hospit health system
referr volum pull forward volum share shift away labcorp
ahead manag care contract open notabl state
highlight investor day opportun gain share
georgia new jersey histor labcorp strong foothold
advers weather condit nationwid includ california fire
labcorp announc come heel disappoint
downward guid two day ago sourc earn revis
differ labcorp guid driven volum
seem mostli relat price see convers manag
care compani today suggest chang underli demand
denial guidelin despit comment
cover steve beuchaw recent point step manag care
new estim lower estim model revenu
billion versu billion previous manag guidanc
billion billion model ep versu post-announc
consensu guidanc model ep
versu post-announc consensu impli guidanc
model revenu billion versu
billion previous model ep versu previous
post-announc consensu
updat price lower price target see
exhibit price target bridg new dcf base target base follow
assumpt near-term top-lin growth medium-term growth
normal covanc top-lin growth termin growth rate
wacc
net net today guid point structur chang lab
dynam valuat reflect strength covanc busi
laboratori corp america hold lh lh us
 distribut unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
account oper incom grow
upsid estim includ increas share buyback commun
manag share gain aetna contract open fulli
reflect model
laboratori corp america lh ow
laboratori corp america lh ow
base case dcf includ termin growth wacc
impli price-to-earnings bull case ep
impli price-to-earnings bull case ep
covanc top-lin growth higher termin growth rate
impli price-to-earnings base case ep
price-to-earnings base case ep
near-term mid-term growth covanc top-lin growth normal
follow integr chiltern acquisit termin growth rate
impli bear case ep
impli bear case ep
lab util slow chiltern acquisit underperform covanc struggl
see top-lin growth termin growth rate
labcorp second largest refer lab
compani matur industri
plan open lab contract
establish long-term strateg partnership
labcorp quest diagnost
set stage ration price share
gain opportun posit lab
rel safe haven within hc servic
headwind reimburs
pressur exposur quantifi
factor ms/market expect
diversifi labcorp busi faster
strateg partnership larg pharma
acquisit lcd cdd
risk achiev price
reimburs pressur may greater
expect
covanc chiltern deal synergi
valuat methodolog risk
lh ow pt dcf deriv pt assum wacc
expect reimburs pressur covanc chiltern deal synergi
ow pt dcf deriv base case price target impli price-to-earnings
base case ep termin growth rate wacc risk includ
volum growth/ share gain expect price eros cost save
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report ricki
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
import us regulatori disclosur subject compani
octob benefici own class common equiti secur follow compani cover morgan
stanley research athenahealth inc health corp laboratori corp america hold
within last month manag co-manag public offer offer secur inc
within last month receiv compens invest bank servic amerisourcebergen corp inc charl
next month expect receiv intend seek compens invest bank servic allscript healthcar
diplomat pharmaci inc express script inc laboratori corp america hold mckesson corpor
within last month receiv compens product servic invest bank servic
within last month provid provid invest bank servic invest bank client relationship
follow compani inc amerisourcebergen corp athenahealth inc inc
corp america hold mckesson corpor medidata solut inc
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani amerisourcebergen corp
employe director consult director health corp person research analyst member research
 co llc make market secur amerisourcebergen corp
inc cerner corpor health corp diplomat pharmaci inc express script inc laboratori corp
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
